ERIS Lifescience

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE406M01024
  • NSEID: ERIS
  • BSEID: 540596
INR
1,393.40
11 (0.8%)
BSENSE

Aug 10, 03:57 PM

BSE+NSE Vol: 38.17 k

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryERIS Lifescience VS Pharmaceuticals & Biotechnology
 
1D
0.8%
0.05%
1W
0.74%
-0.77%
1M
-2.64%
1.56%
YTD
-7.45%
-5.92%
1Y
-19.23%
0.91%
3Y
68.26%
25.79%
5Y
86.2%
51.01%
10Y
%
186.68%
  • Stock Absolute Returns
  • India SENSEXAbsolute Returns
stock-summaryPrice + Dividend
Total Returns (Price + Dividend) stock-summary
Dividend Yield (0.52%)
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
0.53%
0.53%
1.06%
6 Months
-4.91%
0.49%
-4.42%
1 Year
-19.23%
0.42%
-18.81%
2 Years
16.31%
1.20%
17.51%
3 Years
68.26%
1.82%
70.08%
4 Years
100.11%
2.07%
102.18%
5 Years
86.2%
2.87%
89.07%

Latest dividend: 7.21 per share ex-dividend date: May-29-2026

stock-summaryReturn Quartiles
What is a Quartile?

Quartile analysis gives a quick view of the performance of the stock with its peers and with the overall market. Companies are bucketed in 4 Quartiles as per their total returns generated; with each quartile consisting of 25% of the companies in the category.


Example: If there are 20 companies in an industry, the top 5 return giving companies would be bucketed in 1st quartile, next 5 companies in 2nd quartile and so on

Return Quartiles - by Closest Peers stock-summary
Inconsistent Performance

ERIS Lifesciences Ltd has not been a consistent performer in the YTD and longer periods

4
Quartile
quartile-4
QTD
-3.56%
3
Quartile
quartile-3
Mar-Jun
10.51%
3
Quartile
quartile-3
Dec-Mar
-13.84%
4
Quartile
quartile-4
YTD
-19.87%
1
Quartile
quartile-1
2025
9.6%
2
Quartile
quartile-2
2024
50.96%
Click on any of the quartiles for detailed breakdown
Return Quartiles - by Industry stock-summary
Inconsistent Performance

ERIS Lifesciences Ltd has not been a consistent performer in the YTD and longer periods

3
Quartile
quartile-3
QTD
-3.56%
4
Quartile
quartile-4
Mar-Jun
10.51%
2
Quartile
quartile-2
Dec-Mar
-13.84%
4
Quartile
quartile-4
YTD
-19.87%
1
Quartile
quartile-1
2025
9.6%
2
Quartile
quartile-2
2024
50.96%
Click on any of the quartiles for detailed breakdown
Return Quartiles - by Market Cap stock-summary
Inconsistent Performance

ERIS Lifesciences Ltd has not been a consistent performer in the YTD and longer periods

3
Quartile
quartile-3
QTD
-3.56%
4
Quartile
quartile-4
Mar-Jun
10.51%
2
Quartile
quartile-2
Dec-Mar
-13.84%
3
Quartile
quartile-3
YTD
-19.87%
1
Quartile
quartile-1
2025
9.6%
2
Quartile
quartile-2
2024
50.96%
Click on any of the quartiles for detailed breakdown
stock-summaryRisk Adjusted Returns v/s India SENSEX
Risk Adjusted Returns v/s stock-summary
stock-summaryReturns Beta
Returns Beta
Icon
Beta has not been calculated since enough price history is not available